- Home
- MTSI vs RVMD Comparison
MTSI vs RVMD Comparison
Compare MTSI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | RVMD |
|---|---|---|
| Founded | 1950 | 2014 |
| Country | United States | United States |
| Employees | N/A | 883 |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 19.1B |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTSI | RVMD |
|---|---|---|
| Price | $238.03 | $99.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 17 |
| Target Price | ★ $242.89 | $120.47 |
| AVG Volume (30 Days) | 1.0M | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $967,258,000.00 | N/A |
| Revenue This Year | $23.55 | N/A |
| Revenue Next Year | $17.74 | $408.69 |
| P/E Ratio | $358.48 | ★ N/A |
| Revenue Growth | ★ 32.58 | N/A |
| 52 Week Low | $84.10 | $29.17 |
| 52 Week High | $258.98 | $124.49 |
Technical Indicators
Market Signals| Indicator | MTSI | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 54.87 |
| Support Level | $203.12 | $93.86 |
| Resistance Level | $252.55 | $107.45 |
| Average True Range (ATR) | 12.74 | 3.14 |
| MACD | 0.72 | 0.33 |
| Stochastic Oscillator | 81.85 | 82.49 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.